Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China

The National Medical Products Administration has authorized sodium oligomannate for treating mild-to-moderate Alzheimer's disease. In this study, an LC-MS/MS method was developed and validated to quantitate sodium oligomannate in different biomatrices. The plasma pharmacokinetics, tissue distri...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiaojiao, Pan, Qiongqun, Zhou, Jieqiang, Weng, Yan, Chen, Kaili, Shi, Lv, Zhu, Guanxiu, Chen, Chunlin, Li, Liang, Geng, Meiyu, Zhang, Zhenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073255/
https://www.ncbi.nlm.nih.gov/pubmed/35573885
http://dx.doi.org/10.1016/j.jpha.2021.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073255/
https://www.ncbi.nlm.nih.gov/pubmed/35573885
http://dx.doi.org/10.1016/j.jpha.2021.06.001

Ejemplares similares